Science, Synthetic Biology, Best of 2016, Fashion, Big Data.
regulatory committees to begin human trials of CRISPR-engineered, targeted cell therapies. A group led by oncologist Lu You of Sichuan University were the first to initiate the trial and is currently treating a patient with aggressive lung cancer for whom all other therapies have failed. The